Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
暂无分享，去创建一个
S. Madhi | J. Bhiman | K. Dheda | A. Pollard | S. Barnabas | T. Lambe | Faeezah Patel | S. Rhead | S. Pillay | K. Ahmed | M. Malahleha | L. Fairlie | H. Tegally | C. Cutland | T. Villafana | V. Baillie | A. Izu | A. Esmail | A. Koen | G. Kwatra | Shi-Hsia Hwa | S. Gilbert | Q. Bhorat | S. Padayachee | E. Horne | S. Oelofse | S. Mckenzie | J. du Plessis | H. Rodel | C. Briner | S. Bhikha | Aylin Oommen-Jose | C. Taoushanis | A. Thombrayil | M. Laubscher | G. Benadé